Genesis Therapeutics
Pairing proven drug developers with the industry's most advanced small molecule discovery platform, to accelerate and optimize the development of new medicines.
4
Funding Rounds
$56.1m
Money raised
Overview
Pairing proven drug developers with the industry's most advanced small molecule discovery platform, to accelerate and optimize the development of new medicines.
-
Website:
- Business model: UNKNOWN
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Genesis Therapeutics has raised a total of $4.1m in funding over 4 rounds.
Key Insights:
- Genesis Therapeutics Seed round, November 2019: $4.1m
- Genesis Therapeutics Series A round December 2020: $52m
Genesis Therapeutics Seed round, November 2019
$4.1m
Genesis Therapeutics Series A round December 2020
$52m
Industries
Genesis Therapeutics is active in the following industries: